Standard testing plus PET/CT scanning vs standard testing alone: All‐cause mortality1
Standard testing plus PET/CT scanning showed no clear difference in all‐cause mortality1 compared with standard testing alone (moderate certainty).
What each review found
Current versions only| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Standard testing plus PET/CT scanning vs standard testing alone All‐cause mortality1 · people with unprovoked VTE Standard testing plus PET/CT scanning showed no clear difference in all‐cause mortality1 compared with standard testing alone (moderate certainty). Effect of testing for cancer on cancer‐ or venous thromboembolism (VTE)‐related mortality and morbidity in… (2021) · Cochrane Headline outcomes only | OR 1.22 [0.49, 3.04] | 2 studies · 1248 participants | Moderate |
Standard testing plus PET/CT scanning vs standard testing alone All‐cause mortality1 · people with unprovoked VTE Standard testing plus PET/CT scanning showed no clear difference in all‐cause mortality1 compared with standard testing alone (moderate certainty). Effect of testing for cancer on cancer‐ or venous thromboembolism (VTE)‐related mortality and morbidity in… (2018) · Cochrane Headline outcomes onlyearlier version CD010837.PUB4, superseded | OR 1.22 [0.49, 3.04] | 2 studies · 1248 participants | Moderate |
Standard testing plus PET/CT scanning vs standard testing alone All‐cause mortality1 · people with unprovoked VTE Standard testing plus PET/CT scanning showed no clear difference in all‐cause mortality1 compared with standard testing alone (moderate certainty). Effect of testing for cancer on cancer‐ or venous thromboembolism (VTE)‐related mortality and morbidity in… (2017) · Cochrane Headline outcomes onlyearlier version CD010837.PUB3, superseded | OR 1.22 [0.49, 3.04] | 2 studies · 1248 participants | Moderate |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Effect of testing for cancer on cancer‐ or venous thromboembolism (VTE)‐related mortality and morbidity in people with unprovoked VTE 2021 · Cochrane Headline outcomes only | Not reported | list not extracted yet | Not assessed |
Studies behind the findings
None of these reviews ties its included studies to this outcome in the data here. Cochrane reviews and reviews with headline outcomes only do not list their studies yet.
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.